In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Treatment and Survival for High-Grade Spinal Gliomas – A Surveillance, Epidemiology, and End Results (SEER) Study

    Final Number:
    1622

    Authors:
    Wuyang Yang MD, MS; Judy Huang MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: High grade spinal gliomas are an extremely rare entity in the literature. Only sporadic cases have been reported, and overall survival remains unclear. We aim to characterize post-treatment prognosis of these tumors with attempt to find factors influencing survival using the SEER database.

    Methods: We examined all patients with gliomas located in spinal cord or cauda equina. WHO-grade was first determined by site-specific factor 1(WHO-grade), then supplemented by direct review of ICD-O-3 histology. Only grade 3/4 were included in this study. Multivariable Cox regression analysis was performed. Due to small sample size, a step-wise Akaike information criterion(AIC) was performed for full model to select variables into an optimized multivariable model, with forced inclusion of treatment-related variables and variables that were significant in the full model.

    Results: A total of 165 high-grade spinal cord gliomas with 118 glioblastomas(GBM) were included. Mean age at diagnosis was 37.5 years with 36.8% male. Median survival of all patients was 25 months. The overall survival for 1-year, 2-year, 3-year is 71.3%, 51.2%, and 40.7%, respectively. A stepwise AIC was performed, with forced inclusion of patient age, tumor extension, surgery extent and postoperative radiation. The final model after step-wise AIC selection added tumor size in addition to these four variables. Distant tumor invasion(HR:1.74,p=0.043), GTR/TR(HR:2.38,p=0.037) were found to be significant risk factors, while postoperative radiation is a significant protective factor(HR:0.55,p=0.033). Age over 60(HR:1.73,p=0.072) and partial resection(HR:1.91,p=0.065) were borderline risk factors.

    Conclusions: Prognosis of high-grade spinal glioma is poor with median survival of 25 months. Distant tumor invasion and elderly age are risk factors for poor survival. Surgical resection is also a risk factor, which deserves further investigation. Post-operative radiation significantly improves survival and should be recommended.

    Patient Care: The characterization of overall survival and associated risk factors with this rare entity will improve the understanding of progression of this disease.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1. Understand the median and 2-year survival of spinal glioma patients 2. Understand that tumor extension is a significant risk factor in these patients 3. Understand that post-operative radiation therapy poses significant survival benefit in these patients

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy